{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:20:18Z","timestamp":1778620818760,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["2013LZLY-J40"],"award-info":[{"award-number":["2013LZLY-J40"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["14JC0144"],"award-info":[{"award-number":["14JC0144"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.110026","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T17:42:44Z","timestamp":1679074964000},"page":"110026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer"],"prefix":"10.1016","volume":"117","author":[{"given":"Shuya","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanshan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuru","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaozhi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2023.110026_b0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41568-020-0266-x","article-title":"Key steps for effective breast cancer prevention","volume":"20","author":"Britt","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2023.110026_b0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-med-042716-103422","article-title":"Novel radiotherapy techniques for breast cancer","volume":"69","author":"Bradley","year":"2018","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110026_b0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1677\/erc.0.0060041","article-title":"Induction of cell death by radiotherapy","volume":"6","author":"Ross","year":"1999","journal-title":"Endocr. Relat. Cancer"},{"issue":"305","key":"10.1016\/j.intimp.2023.110026_b0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole body irradiation; radiobiology or medicine?","volume":"26","author":"Mole","year":"1953","journal-title":"Br. J. Radiol."},{"issue":"13","key":"10.1016\/j.intimp.2023.110026_b0025","first-page":"3212","article-title":"Tumor Microenvironment as A \u201cGame Changer\u201d in Cancer Radiotherapy","volume":"20","author":"Jarosz-Biej","year":"2019","journal-title":"Tumor Microenvironment as A \u201cGame Changer\u201d in Cancer Radiotherapy. International journal of molecular sciences"},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0030","doi-asserted-by":"crossref","first-page":"e000826","DOI":"10.1136\/jitc-2020-000826","article-title":"Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer","volume":"8","author":"Ji","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.110026_b0035","doi-asserted-by":"crossref","first-page":"e1507669","DOI":"10.1080\/2162402X.2018.1507669","article-title":"Combination PD-1 blockade and irradiation of brain metastasis induces an effective abscopal effect in melanoma","volume":"8","author":"Pfannenstiel","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2023.110026_b0040","doi-asserted-by":"crossref","unstructured":"C.I. Ene et al., Anti-PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma, Neuro-oncology 22 (5) (2020) 639\u2013651. doi:10.1093\/neuonc\/noz226.","DOI":"10.1093\/neuonc\/noz226"},{"issue":"1","key":"10.1016\/j.intimp.2023.110026_b0045","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0704-z","article-title":"Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer","volume":"7","author":"Dudzinski","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.110026_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.110026_b0055","doi-asserted-by":"crossref","unstructured":"M.Z. Dewan et al., Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 15 (17) (2009) 5379\u20135388. doi:10.1158\/1078-0432.CCR-09-0265.","DOI":"10.1158\/1078-0432.CCR-09-0265"},{"key":"10.1016\/j.intimp.2023.110026_b0060","doi-asserted-by":"crossref","unstructured":"A. Roger et al., Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients. Oncoimmunology 7 (7) (2018) e1442166. doi:10.1080\/2162402x.2018.1442166.","DOI":"10.1080\/2162402X.2018.1442166"},{"issue":"6","key":"10.1016\/j.intimp.2023.110026_b0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","article-title":"The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant","volume":"41","author":"Reynders","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.intimp.2023.110026_b0070","doi-asserted-by":"crossref","unstructured":"X. Zhao, C. Shao, Radiotherapy-mediated immunomodulation and anti-tumor abscopal effect combining immune checkpoint blockade, Cancers 12 (10) (2020). doi:10.3390\/cancers12102762.","DOI":"10.3390\/cancers12102762"},{"issue":"12","key":"10.1016\/j.intimp.2023.110026_b0075","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7\u2013H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion","volume":"5","author":"Dong","year":"1999","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.110026_b0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1470-2045(21)00065-6","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG\/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial","volume":"22","author":"Eggermont","year":"2021","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jtho.2021.09.010","article-title":"First-line nivolumab plus ipilimumab in advanced NSCLC: 4-year outcomes from the randomized, open-label, phase 3 checkmate 227 part 1 trial","volume":"17","author":"Paz-Ares","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110026_b0090","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijrobp.2020.05.002","article-title":"Effect of low-dose radiation therapy on abscopal responses to hypofractionated radiation therapy and anti-PD1 in mice and patients with non-small cell lung cancer","volume":"108","author":"Yin","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2217\/imt-2018-0049","article-title":"\u03b1-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8(+) T-cell infiltration","volume":"11","author":"Wang","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.intimp.2023.110026_b0100","doi-asserted-by":"crossref","unstructured":"M.S. Caetano et al., Triple therapy with MerTK and PD1 inhibition plus radiotherapy promotes abscopal antitumor immune responses. Clin. Cancer Res.: off. J. Am. Assoc. Cancer Res. 25 (24) (2019) 7576\u20137584. doi:10.1158\/1078-0432.ccr-19-0795.","DOI":"10.1158\/1078-0432.CCR-19-0795"},{"issue":"7","key":"10.1016\/j.intimp.2023.110026_b0105","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00262-017-1993-z","article-title":"Cancer immunotherapy: how low-level ionizing radiation can play a key role","volume":"66","author":"Janiak","year":"2017","journal-title":"Cancer Immunol. Immunother.: CII"},{"key":"10.1016\/j.intimp.2023.110026_b0110","article-title":"Low-Dose total body irradiation can enhance systemic immune related response induced by hypo-fractionated radiation","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"issue":"7547","key":"10.1016\/j.intimp.2023.110026_b0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110026_b0120","doi-asserted-by":"crossref","unstructured":"M.E. Rodriguez-Ruiz et al., Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming, Cancer Res. 76 (20) (2016) 5994\u20136005. doi:10.1158\/0008-5472.can-16-0549.","DOI":"10.1158\/0008-5472.CAN-16-0549"},{"issue":"5","key":"10.1016\/j.intimp.2023.110026_b0125","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.180.5.3132","article-title":"Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity","volume":"180","author":"Lugade","year":"2008","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110026_b0130","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110026_b0135","first-page":"65","article-title":"Radiotherapy combination opportunities leveraging immunity for the next oncology practice","volume":"67","author":"Herrera","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1189\/jlb.1202587","article-title":"Analysis of the maturation process of dendritic cells deficient for TNF and lymphotoxin-alpha reveals an essential role for TNF","volume":"74","author":"Ritter","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2023.110026_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01680","article-title":"The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion","volume":"11","author":"De Cicco","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110026_b0150","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-120","article-title":"A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease","volume":"12","author":"Kaur","year":"2012","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2023.110026_b0155","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2214\/ajr.120.3.504","article-title":"Proceedings: total body irradiation in the treatment of chronic lymphogenous leukemia","volume":"120","author":"Del Regato","year":"1974","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0360-3016(97)00722-0","article-title":"Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study","volume":"40","author":"Richaud","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.intimp.2023.110026_b0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1667\/RR3123","article-title":"Single low doses of X rays inhibit the development of experimental tumor metastases and trigger the activities of NK cells in mice","volume":"161","author":"Cheda","year":"2004","journal-title":"Radiat. Res."},{"key":"10.1016\/j.intimp.2023.110026_b0170","doi-asserted-by":"crossref","unstructured":"L.E. Feinendegen et al., Low-dose cancer risk modeling must recognize up-regulation of protection. Dose-response : a publication of International Hormesis Society 8 (2) (2009) 227\u2013252. doi:10.2203\/dose-response.09-035.Feinendegen.","DOI":"10.2203\/dose-response.09-035.Feinendegen"},{"issue":"3","key":"10.1016\/j.intimp.2023.110026_b0175","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1667\/0033-7587(2003)159[0320:LDORIT]2.0.CO;2","article-title":"Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone, radiation-sensitive Trp53 heterozygous mice","volume":"159","author":"Mitchel","year":"2003","journal-title":"Radiat. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110026_b0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1667\/RR3190","article-title":"Upper dose thresholds for radiation-induced adaptive response against cancer in high-dose-exposed, cancer-prone, radiation-sensitive Trp53 heterozygous mice","volume":"162","author":"Mitchel","year":"2004","journal-title":"Radiat. Res."},{"issue":"10","key":"10.1016\/j.intimp.2023.110026_b0185","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.3390\/ijms22105150","article-title":"Atovaquone suppresses triple-negative breast tumor growth by reducing immune-suppressive cells","volume":"22","author":"Gupta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5 Pt 1","key":"10.1016\/j.intimp.2023.110026_b0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1667\/0033-7587(2000)153[0599:TIOLDT]2.0.CO;2","article-title":"The immunobiology of low-dose total-body irradiation: more questions than answers","volume":"153","author":"Safwat","year":"2000","journal-title":"Radiat. Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110026_b0200","doi-asserted-by":"crossref","unstructured":"D. Kazandjian et al., Avelumab, a PD-L1 Inhibitor, in combination with hypofractionated radiotherapy and the abscopal effect in relapsed refractory multiple myeloma. Oncologist 26 (4) (2021) 288-e541. doi:10.1002\/onco.13712.","DOI":"10.1002\/onco.13712"},{"issue":"10","key":"10.1016\/j.intimp.2023.110026_b0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2016.79","article-title":"Clinical development of new drug-radiotherapy combinations","volume":"13","author":"Sharma","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.110026_b0210","doi-asserted-by":"crossref","unstructured":"B.R. Scott, Low-dose radiation-induced protective process and implications for risk assessment, cancer prevention, and cancer therapy. Dose-response : a publication of International Hormesis Society 5 (2) (2007) 131\u2013149. doi:10.2203\/dose-response.05-037.Scott.","DOI":"10.2203\/dose-response.05-037.Scott"},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/0960327107083411","article-title":"Low-dose radioimmuno-therapy of cancer","volume":"27","author":"Pollycove","year":"2008","journal-title":"Hum. Exp. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110026_b0220","first-page":"169","article-title":"Radiation hormesis: the good, the bad, and the ugly","volume":"4","author":"Luckey","year":"2006","journal-title":"Dose-Resp.: Publ. Int. Hormesis Soc."},{"issue":"4636","key":"10.1016\/j.intimp.2023.110026_b0225","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1126\/science.6695170","article-title":"Adaptive response of human lymphocytes to low concentrations of radioactive thymidine","volume":"223","author":"Olivieri","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110026_b0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"Karin","year":"2018","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2023.110026_b0235","doi-asserted-by":"crossref","first-page":"e000599","DOI":"10.1136\/jitc-2020-000599","article-title":"Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-\u03b3, CXCL9 and CXCL10","volume":"8","author":"Bergamaschi","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/cmi.2009.117","article-title":"Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells","volume":"7","author":"Liu","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.110026_b0245","doi-asserted-by":"crossref","unstructured":"F.G. Herrera et al., Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy. Cancer Disc. 12 (1) (2022) 108\u2013133. doi:10.1158\/2159-8290.cd-21-0003.","DOI":"10.1158\/2159-8290.CD-21-0003"},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0250","doi-asserted-by":"crossref","first-page":"e000537","DOI":"10.1136\/jitc-2020-000537","article-title":"Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma","volume":"8","author":"Barsoumian","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2023.110026_b0255","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/eji.1830200511","article-title":"Tumor necrosis factor-alpha and interleukin 6 synergistically induce T cell growth","volume":"20","author":"Kuhweide","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2023.110026_b0260","doi-asserted-by":"crossref","unstructured":"X. Ding et al., TNF receptor 1 mediates dendritic cell maturation and CD8 T cell response through two distinct mechanisms. J. Immunol. 187 (3) (2011) 1184\u20131191. doi:10.4049\/jimmunol.1002902.","DOI":"10.4049\/jimmunol.1002902"},{"issue":"9","key":"10.1016\/j.intimp.2023.110026_b0265","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.intimp.2023.110026_b0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00262-015-1772-7","article-title":"Increasing radiation dose improves immunotherapy outcome and prolongation of tumor dormancy in a subgroup of mice treated for advanced intracerebral melanoma","volume":"65","author":"Smilowitz","year":"2016","journal-title":"Cancer Immunol. Immunother.: CII"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923003478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923003478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:56:27Z","timestamp":1778619387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923003478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":54,"alternative-id":["S1567576923003478"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110026","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110026"}}